TipRanks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Income Statement

252 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q1 2027), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Medicenna Therapeutics Corp's net income was C$-5.08M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 23Mar 22Mar 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -77.00KC$ -55.00KC$ -5.00KC$ -38.00KC$ -40.00K
Operating Expenses
C$ 23.63MC$ 21.58MC$ 19.66MC$ 22.47MC$ 17.39M
Depreciation and Amortization
C$ 77.00KC$ 55.00KC$ 5.00KC$ 38.00KC$ 40.00K
EBITDA
C$ -23.63MC$ -12.97MC$ -18.67MC$ -22.54MC$ -17.25M
Operating Income
C$ -23.71MC$ -21.63MC$ -19.66MC$ -22.30MC$ -17.19M
Other Income/Expenses
C$ 4.01MC$ 8.60MC$ -5.80MC$ 1.65MC$ 106.00K
Pretax Income
C$ -19.70MC$ -13.03MC$ -25.47MC$ -22.58MC$ -17.29M
Net Income
C$ -18.41MC$ -11.80MC$ -25.47MC$ -22.65MC$ -17.18M
Per Share Metrics
Basic EPS
C$ -0.22C$ -0.15C$ -0.37C$ -0.42C$ -0.35
Diluted EPS
C$ -0.22C$ -0.15C$ -0.37C$ -0.42C$ -0.35
Weighted Average Shares Outstanding
 83.19M 76.67M 69.64M 54.29M 49.66M
Weighted Average Shares Outstanding (Diluted)
 83.19M 76.67M 69.64M 54.29M 49.66M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History